XML 59 R49.htm IDEA: XBRL DOCUMENT v3.22.2.2
Common Stock and Stockholders' Equity (Deficit) - Additional Information (Details) - USD ($)
3 Months Ended 6 Months Ended
Jul. 31, 2022
Apr. 30, 2022
Apr. 30, 2021
Jul. 31, 2022
Jul. 31, 2021
Jan. 31, 2022
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]            
Common stock capital shares reserved for future issuance 49,024,402     49,024,402   42,248,307
Stock-based compensation expense   $ 42,403,000 $ 1,498,000 $ 88,662,000 $ 3,224,000  
Unrecognized stock-based compensation expense $ 2,900,000     $ 2,900,000    
Unrecognized stock-based compensation expense, weighted-average period       1 year 4 months 24 days    
Exercisable shares vested 9,750,090     9,750,090    
Unvested early exercise provision 750     750    
Total grant-date fair value of stock options vested       $ 2,800,000 3,400,000  
Total intrinsic value of options exercised       59,500,000 35,200,000  
Cash proceeds from common stock       8,501,000    
Accrued compensation and benefits $ 54,978,000     $ 54,978,000   $ 56,939,000
2021 Plan            
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]            
Options granted 0     0    
Total intrinsic value of options exercised       $ 59,482,000    
Number of shares available for sale 23,084,726     23,084,726   17,560,879
2021 Employee Stock Purchase Plan            
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]            
Common stock capital shares reserved for future issuance 3,370,329     3,370,329   1,900,000
Stock-based compensation expense       $ 7,300,000    
Unrecognized stock-based compensation expense $ 22,600,000     $ 22,600,000    
Unrecognized stock-based compensation expense, weighted-average period       1 year 10 months 24 days    
Employee stock purchase plan, share issued       351,284    
Purchase price per share $ 24.20     $ 24.20    
Cash proceeds from common stock       $ 8,500,000    
Accrued compensation and benefits $ 4,100,000     $ 4,100,000 0  
Rollover offering period       2 years    
Rollover closing stock price period       Jun. 15, 2022    
Closing stock price period       Dec. 08, 2021    
Offering period       24 months    
Offering period date       Jun. 15, 2024    
Incremental compensation cost recognized due to modification       $ 4,900,000    
Restricted Stock Units            
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]            
Common stock capital shares reserved for future issuance 11,985,438     11,985,438   10,406,294
Unrecognized stock-based compensation expense $ 390,600,000     $ 390,600,000    
Unrecognized stock-based compensation expense, weighted-average period       2 years 4 months 24 days    
Grant-date fair value of vested shares       $ 64,900,000 $ 0  
Common Class A | 2021 Plan            
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]            
Common stock capital shares reserved for future issuance 23,084,726     23,084,726    
Common Class A | 2021 Employee Stock Purchase Plan            
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]            
Number of shares available for sale 3,370,329     3,370,329